Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024年10月8日 - 6:07AM
Edgar (US Regulatory)
Exhibit 99.1
The identity and the Item 3 classification of the relevant subsidiary is: Bleichroeder LP, which is an Investment Adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
Cue Biopharma (NASDAQ:CUE)
過去 株価チャート
から 1 2025 まで 2 2025
Cue Biopharma (NASDAQ:CUE)
過去 株価チャート
から 2 2024 まで 2 2025